Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Aug;41(2):865–868. doi: 10.1128/iai.41.2.865-868.1983

Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington.

C C Kuo, S P Wang, K K Holmes, J T Grayston
PMCID: PMC264725  PMID: 6874078

Abstract

The immunotype distribution of 493 Chlamydia trachomatis isolates from 467 adults and 26 infants in the Seattle area from 1965 to 1982 is presented. All except one of the isolates from adults were from the genitourinary tract, rectum, or bubo. The proportions of each immunotype were ED, 46.5%; GF, 24.6%; H, I, J/CJ, and K, 5 to 7% each; B, 3.5%; and L2, 1%.

Full text

PDF
866

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E. R., Wang S. P., Grayston J. T. Further characterization of TRIC agent strains of genital origin. Rev Int Trach. 1968;45(4):297–310. [PubMed] [Google Scholar]
  2. Alexander E. R., Wang S. P., Grayston J. T. Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol. 1967 May;63(5 Suppl):1469–1478. doi: 10.1016/0002-9394(67)94133-5. [DOI] [PubMed] [Google Scholar]
  3. Dwyer R. S., Treharne J. D., Jones B. R., Herring J. Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections. Br J Vener Dis. 1972 Dec;48(6):452–459. doi: 10.1136/sti.48.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GORDON F. B., QUAN A. L. ISOLATION OF THE TRACHOMA AGENT IN CELL CULTURE. Proc Soc Exp Biol Med. 1965 Feb;118:354–359. doi: 10.3181/00379727-118-29841. [DOI] [PubMed] [Google Scholar]
  5. Grayston J. T., Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis. 1975 Jul;132(1):87–105. doi: 10.1093/infdis/132.1.87. [DOI] [PubMed] [Google Scholar]
  6. Kuo C. C., Wang S. P., Grayston J. T., Alexander E. R. TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol. 1974 Aug;113(2):591–596. [PubMed] [Google Scholar]
  7. Kuo C. C., Wang S. P., Grayston J. T. Comparative infectivity of trachoma organisms in HeLa 229 cells and egg cultures. Infect Immun. 1975 Nov;12(5):1078–1082. doi: 10.1128/iai.12.5.1078-1082.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kuo C., Chen W. J. A mouse model of Chlamydia trachomatis pneumonitis. J Infect Dis. 1980 Feb;141(2):198–202. doi: 10.1093/infdis/141.2.198. [DOI] [PubMed] [Google Scholar]
  9. Kuo C., Wang S., Wentworth B. B., Grayston J. T. Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis. 1972 Jun;125(6):665–668. doi: 10.1093/infdis/125.6.665. [DOI] [PubMed] [Google Scholar]
  10. Ripa K. T., Mårdh P. A. Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells. J Clin Microbiol. 1977 Oct;6(4):328–331. doi: 10.1128/jcm.6.4.328-331.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schachter J. Chlamydial infections (third of three parts). N Engl J Med. 1978 Mar 9;298(10):540–549. doi: 10.1056/NEJM197803092981005. [DOI] [PubMed] [Google Scholar]
  12. TANG F. F., CHANG H. L., HUANG Y. T., WANG K. C. Studies on the etiology of trachoma with special reference to isolation of the virus in chick embryo. Chin Med J. 1957 Jun;75(6):429–447. [PubMed] [Google Scholar]
  13. Wang S. P., Grayston J. T., Gale J. L. Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol. 1973 Mar;110(3):873–879. [PubMed] [Google Scholar]
  14. Wang S. P., Kuo C. C., Grayston J. T. A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun. 1973 Mar;7(3):356–360. doi: 10.1128/iai.7.3.356-360.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wang S., Grayston J. T. Chlamydia trachomatis immunotype J. J Immunol. 1975 Dec;115(6):1711–1716. [PubMed] [Google Scholar]
  16. Wentworth B. B., Alexander E. R. Isolation of Chlamydia trachomatis by use of 5-iodo-2-deoxyuridine-treated cells. Appl Microbiol. 1974 May;27(5):912–916. doi: 10.1128/am.27.5.912-916.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES